91 related articles for article (PubMed ID: 7911188)
21. Detecting life-threatening lactic acidosis related to nucleoside-analog treatment of human immunodeficiency virus-infected patients, and treatment with L-carnitine.
Claessens YE; Cariou A; Monchi M; Soufir L; Azoulay E; Rouges P; Goldgran-Toledano D; Branche F; Dhainaut JF
Crit Care Med; 2003 Apr; 31(4):1042-7. PubMed ID: 12682470
[TBL] [Abstract][Full Text] [Related]
22. Tenofovir alafenamide associated fatal lactic acidosis in an autologous hematopoietic stem cell transplant recipient.
Alsunaid SR; Ashraf H; Soubani AO
Transpl Infect Dis; 2018 Oct; 20(5):e12960. PubMed ID: 29975806
[TBL] [Abstract][Full Text] [Related]
23. Effects of fialuridine on hepatitis B immune globulin pharmacokinetics following orthotopic liver transplant for chronic hepatitis B viral-induced cirrhosis.
McGory RW; Ishitani MB; Oliveira WM; Stevenson WC; Dickson RC; Caldwell SH; Pruett TL
Transplant Proc; 1995 Feb; 27(1):1213-4. PubMed ID: 7878854
[No Abstract] [Full Text] [Related]
24. Concern grows over reaction to deaths in clinical trials.
Macilwain C
Nature; 1994 May; 369(6478):268. PubMed ID: 8183354
[No Abstract] [Full Text] [Related]
25. Lactic acidosis during Entecavir treatment in decompensated hepatitis B virus-related cirrhosis.
Marzano A; Marengo A; Marietti M; Rizzetto M
Dig Liver Dis; 2011 Dec; 43(12):1027-8. PubMed ID: 21782535
[No Abstract] [Full Text] [Related]
26. Panel clears NIH in patient deaths.
Stone R
Science; 1995 Mar; 267(5205):1759. PubMed ID: 7892593
[No Abstract] [Full Text] [Related]
27. Clevudine Induced Mitochondrial Myopathy.
Park SH; Park KS; Kim NH; Cho JY; Koh MS; Lee JH
J Korean Med Sci; 2017 Nov; 32(11):1857-1860. PubMed ID: 28960041
[TBL] [Abstract][Full Text] [Related]
28. Trial deaths prompt tighter rules.
Macilwain C
Nature; 1993 Nov; 366(6453):294. PubMed ID: 8247116
[No Abstract] [Full Text] [Related]
29. Strategic proposals for predicting drug-drug interactions during new drug development: based on sixteen deaths caused by interactions of the new antiviral sorivudine with 5-fluorouracil prodrugs.
Watabe T
J Toxicol Sci; 1996 Dec; 21(5):299-300. PubMed ID: 9035040
[No Abstract] [Full Text] [Related]
30. IOM panel exonerates researchers in FIAU deaths.
Marwick C
JAMA; 1995 Apr; 273(15):1165. PubMed ID: 7707610
[No Abstract] [Full Text] [Related]
31. Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function.
Lange CM; Bojunga J; Hofmann WP; Wunder K; Mihm U; Zeuzem S; Sarrazin C
Hepatology; 2009 Dec; 50(6):2001-6. PubMed ID: 19937695
[TBL] [Abstract][Full Text] [Related]
32. Lactic acidosis in patients with hepatitis C virus cirrhosis and combined ribavirin/sofosbuvir treatment.
Welker MW; Luhne S; Lange CM; Vermehren J; Farnik H; Herrmann E; Welzel T; Zeuzem S; Sarrazin C
J Hepatol; 2016 Apr; 64(4):790-9. PubMed ID: 26658684
[TBL] [Abstract][Full Text] [Related]
33. A possible mechanism of eighteen patient deaths caused by interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs.
Okuda H; Ogura K; Kato A; Takubo H; Watabe T
J Pharmacol Exp Ther; 1998 Nov; 287(2):791-9. PubMed ID: 9808711
[TBL] [Abstract][Full Text] [Related]
34. Fluorinated pyrimidines: a new change for old drugs.
King DH
Transplant Proc; 1991 Jun; 23(3 Suppl 3):168-70. PubMed ID: 1648825
[No Abstract] [Full Text] [Related]
35. Fialuridine toxicity.
Schmid R
Hepatology; 1997 Jun; 25(6):1548. PubMed ID: 9185783
[No Abstract] [Full Text] [Related]
36. Incidental treatment of hepatitis B virus infection in an AIDS patient.
Warner D
AIDS Read; 2000 Jun; 10(6):376. PubMed ID: 10881369
[No Abstract] [Full Text] [Related]
37. Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients.
Liao YP; Jiang JL; Zou WY; Xu DR; Li J
World J Gastroenterol; 2015 Apr; 21(14):4284-92. PubMed ID: 25892880
[TBL] [Abstract][Full Text] [Related]
38. Editorial comment: drug-drug interactions, hepatitis C, and mitochondrial toxicity.
Glesby MJ; Gerber JG
AIDS Read; 2003 Jul; 13(7):346-7. PubMed ID: 12889453
[No Abstract] [Full Text] [Related]
39. [Viral hepatitis B/C and HIV. Therapy of double infections].
Mauss S
MMW Fortschr Med; 2003 Apr; 145 Spec No 1():21-5. PubMed ID: 15011579
[TBL] [Abstract][Full Text] [Related]
40. The need for improving information systems on drug interactions in Japan.
Harada K; Fujimura A
Arch Intern Med; 2000 Jul; 160(13):2063-4. PubMed ID: 10888985
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
